VIATRIS INC. Long-Term Debt, Maturity, Year Two
VIATRIS INC. (VTRS) had Long-Term Debt, Maturity, Year Two of $1.72 billion as of 2025-12-31, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Commitment and Contingencies › Long-Term Debt, Fiscal Year Maturity › Long-Term Debt, Maturity, Year Two and Three
us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo · last filed 2026-08-06
- 2025-12-31: Long-Term Debt, Maturity, Year Two $1.72B; Long-Term Debt, Maturity, Year Two as first filed $1.75B.
- 2024-12-31: Long-Term Debt, Maturity, Year Two $1.95B; Long-Term Debt, Maturity, Year Two as first filed $1.93B.
- 2023-12-31: Long-Term Debt, Maturity, Year Two $325.00M; Long-Term Debt, Maturity, Year Two as first filed $1.30B.
- 2022-12-31: Long-Term Debt, Maturity, Year Two $1.85B; Long-Term Debt, Maturity, Year Two as first filed $1.87B.
| Period end | Long-Term Debt, Maturity, Year Two | Long-Term Debt, Maturity, Year Two as first filed |
|---|---|---|
| 2025-12-31 | $1.72B 10-Q · filed 2026-08-06 | $1.75B 10-K · filed 2026-02-26 |
| 2024-12-31 | $1.95B 10-Q · filed 2025-11-06 | $1.93B 10-K · filed 2025-02-27 |
| 2023-12-31 | $325.00M 10-Q · filed 2024-11-07 | $1.30B 10-K · filed 2024-02-28 |
| 2022-12-31 | $1.85B 10-Q · filed 2023-11-08 | $1.87B 10-K · filed 2023-02-27 |
| 2021-12-31 | $1.25B 10-Q · filed 2022-11-07 | |
| 2020-12-31 | $1.87B 10-Q · filed 2021-11-08 | $2.52B 10-K · filed 2021-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |